{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:03:51Z","timestamp":1789434231161,"version":"build-2803163510"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03511-6","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:30:51Z","timestamp":1789432251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanovesicular Spanlastics Thermosensitive Gel for the Ocular Delivery of Voriconazole: Development, Ex Vivo Transcorneal Permeability, and In Vivo Evaluation in a Rabbit Model of Fungal Keratitis"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-1254","authenticated-orcid":false,"given":"Ghareb M.","family":"Soliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7946-4477","authenticated-orcid":false,"given":"Ayman","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-1168","authenticated-orcid":false,"given":"Mona","family":"Qushawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-9174","authenticated-orcid":false,"given":"Mona F.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5167-3377","authenticated-orcid":false,"given":"Nehal","family":"Elsherbiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1814-0215","authenticated-orcid":false,"given":"Mohamed M.","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-292X","authenticated-orcid":false,"given":"Wael M.","family":"Elsaed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7374-9334","authenticated-orcid":false,"given":"Yasmin N.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"3511_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.698780","author":"K Ahmadikia","year":"1990","unstructured":"Ahmadikia K, Aghaei Gharehbolagh S, Fallah B, Naeimi Eshkaleti M, Malekifar P, Rahsepar S, et al. Distribution, prevalence, and causative agents of fungal keratitis: a systematic review and meta-analysis (1990 to 2020). Front Cell Infect Microbiol. 1990. https:\/\/doi.org\/10.3389\/fcimb.2021.698780.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"3511_CR2","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1021\/acsinfecdis.4c00203","volume":"10","author":"AC Bisen","year":"2024","unstructured":"Bisen AC, Sanap SN, Agrawal S, Biswas A, Mishra A, Verma SK, et al. Etiopathology, epidemiology, diagnosis, and treatment of fungal keratitis. ACS Infect Dis. 2024;10(7):2356\u201380. https:\/\/doi.org\/10.1021\/acsinfecdis.4c00203.","journal-title":"ACS Infect Dis"},{"issue":"12","key":"3511_CR3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/bjo.2005.076315","volume":"89","author":"PA Thomas","year":"2005","unstructured":"Thomas PA, Leck AK, Myatt M. Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi. Br J Ophthalmol. 2005;89(12):1554. https:\/\/doi.org\/10.1136\/bjo.2005.076315.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"3511_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/1469-0691.12126","volume":"19","author":"PA Thomas","year":"2013","unstructured":"Thomas PA, Kaliamurthy J. Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect. 2013;19(3):210\u201320. https:\/\/doi.org\/10.1111\/1469-0691.12126.","journal-title":"Clin Microbiol Infect"},{"key":"3511_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","volume":"24","author":"N Sharma","year":"2022","unstructured":"Sharma N, Bagga B, Singhal D, Nagpal R, Kate A, Saluja G, et al. Fungal keratitis: a review of clinical presentations, treatment strategies and outcomes. Ocul Surf. 2022;24:22\u201330. https:\/\/doi.org\/10.1016\/j.jtos.2021.12.001.","journal-title":"Ocul Surf"},{"issue":"10","key":"3511_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/jof8101067","volume":"8","author":"JJ Hoffman","year":"2022","unstructured":"Hoffman JJ, Arunga S, Mohamed Ahmed AHA, Hu VH, Burton MJ. Management of filamentous fungal keratitis: a pragmatic approach. J Fungi. 2022;8(10):1067. https:\/\/doi.org\/10.3390\/jof8101067.","journal-title":"J Fungi"},{"key":"3511_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/opth.S447138","volume":"18","author":"R Awad","year":"2024","unstructured":"Awad R, Ghaith AA, Awad K, Mamdouh Saad M, Elmassry AA. Fungal keratitis: diagnosis, management, and recent advances. Clin Ophthalmol. 2024;18:85\u2013106. https:\/\/doi.org\/10.2147\/opth.S447138.","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"3511_CR8","doi-asserted-by":"publisher","first-page":"e00247","DOI":"10.1002\/adtp.202500247","volume":"8","author":"M Wang","year":"2025","unstructured":"Wang M, Yang M, Yin H, Li Z, Wang X, Shi L. Fungal keratitis: clinical presentations, mechanism and management strategies. Adv Therap. 2025;8(8):e00247. https:\/\/doi.org\/10.1002\/adtp.202500247.","journal-title":"Adv Therap"},{"issue":"11","key":"3511_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/jof7110907","volume":"7","author":"N Raj","year":"2021","unstructured":"Raj N, Vanathi M, Ahmed NH, Gupta N, Lomi N, Tandon R. Recent perspectives in the management of fungal keratitis. J Fungi. 2021;7(11):907. https:\/\/doi.org\/10.3390\/jof7110907.","journal-title":"J Fungi"},{"issue":"8","key":"3511_CR10","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1007\/s12325-023-02541-x","volume":"40","author":"M Mascarenhas","year":"2023","unstructured":"Mascarenhas M, Chaudhari P, Lewis SA. Natamycin ocular delivery: challenges and advancements in ocular therapeutics. Adv Ther. 2023;40(8):3332\u201359. https:\/\/doi.org\/10.1007\/s12325-023-02541-x.","journal-title":"Adv Ther"},{"issue":"1","key":"3511_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/11206721231174653","volume":"34","author":"F Zhang","year":"2023","unstructured":"Zhang F, Zhang J, Zhang W. Recent advances in nanotechnology for the treatment of fungal keratitis. Eur J Ophthalmol. 2023;34(1):18\u201329. https:\/\/doi.org\/10.1177\/11206721231174653.","journal-title":"Eur J Ophthalmol"},{"issue":"10","key":"3511_CR12","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3390\/jof8101047","volume":"8","author":"L Brown","year":"2022","unstructured":"Brown L, Kamwiziku G, Oladele RO, Burton MJ, Prajna NV, Leitman TM, et al. The case for fungal keratitis to be accepted as a neglected tropical disease. J Fungi. 2022;8(10):1047. https:\/\/doi.org\/10.3390\/jof8101047.","journal-title":"J Fungi"},{"key":"3511_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1618046","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Yang Y, Sun B, Yang M, Lang J, Dong M, et al. Nanomedicine in fungal keratitis: current applications and future prospects. Front Microbiol. 2025. https:\/\/doi.org\/10.3389\/fmicb.2025.1618046.","journal-title":"Front Microbiol"},{"issue":"9","key":"3511_CR14","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/pharmaceutics17091170","volume":"17","author":"R Khotcharrat","year":"2025","unstructured":"Khotcharrat R, Srinivas SP, Thongsri Y, Thongsuk W. In vitro antifungal activity of amphotericin b-encapsulated silk fibroin-chitosan nanoparticles against fusarium solani isolates from keratitis patients. Pharmaceutics. 2025;17(9):1170. https:\/\/doi.org\/10.3390\/pharmaceutics17091170.","journal-title":"Pharmaceutics"},{"key":"3511_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","volume":"92","author":"CK Song","year":"2012","unstructured":"Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation. Colloids Surf B Biointerfaces. 2012;92:299\u2013304. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.12.004.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"3511_CR16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann J\u00f6rgW, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408\u201315. https:\/\/doi.org\/10.1056\/NEJMoa020191.","journal-title":"N Engl J Med"},{"key":"3511_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-025-02021-5","author":"BHJ Gowda","year":"2025","unstructured":"Gowda BHJ, Pandya AK, Gade S, Duncan R, Paredes AJ, Ahmed MG, et al. Voriconazole nanosuspension-loaded ocular bilayer dissolving microneedle patch for the management of fungal keratitis. Drug Deliv Transl Res. 2025. https:\/\/doi.org\/10.1007\/s13346-025-02021-5.","journal-title":"Drug Deliv Transl Res"},{"key":"3511_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010266","author":"L de Almeida Campos","year":"2023","unstructured":"de Almeida Campos L, Fin MT, Santos KS, de Lima Gualque MW, Freire Cabral AKL, Khalil NM, et al. Nanotechnology-based approaches for voriconazole delivery applied to invasive fungal infections. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15010266.","journal-title":"Pharmaceutics"},{"issue":"5","key":"3511_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1086\/367933","volume":"36","author":"LB Johnson","year":"2003","unstructured":"Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis. 2003;36(5):630\u20137. https:\/\/doi.org\/10.1086\/367933.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3511_CR20","doi-asserted-by":"publisher","first-page":"38879","DOI":"10.1038\/s41598-025-22615-w","volume":"15","author":"M Atighehchian","year":"2025","unstructured":"Atighehchian M, Latifi G, Bardan AS, Ouano D, Zarei-Ghanavati S, Abedinifar Z, et al. Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial. Sci Rep. 2025;15(1):38879. https:\/\/doi.org\/10.1038\/s41598-025-22615-w.","journal-title":"Sci Rep"},{"issue":"11","key":"3511_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","volume":"58","author":"A Urtti","year":"2006","unstructured":"Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006;58(11):1131\u20135. https:\/\/doi.org\/10.1016\/j.addr.2006.07.027.","journal-title":"Adv Drug Deliv Rev"},{"key":"3511_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15041091","author":"M Zemba","year":"2023","unstructured":"Zemba M, Radu M, Istrate S, Dumitrescu OM, Ionescu MA, Vatafu A, et al. Intrastromal injections in the management of infectious keratitis. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15041091.","journal-title":"Pharmaceutics"},{"key":"3511_CR23","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.95271","author":"RS Haddad","year":"2012","unstructured":"Haddad RS, El-Mollayess GM. Combination of intracameral and intrastromal voriconazole in the treatment of recalcitrant acremonium fungal keratitis. Middle East Afr J Ophthalmol. 2012. https:\/\/doi.org\/10.4103\/0974-9233.95271.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"3511_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S289828","volume":"16","author":"E Alaaeldin","year":"2021","unstructured":"Alaaeldin E, Abou-Taleb HA, Mohamad SA, Elrehany M, Gaber SS, Mansour HF. Topical nano-vesicular spanlastics of celecoxib: enhanced anti-inflammatory effect and down-regulation of TNF-\u03b1, NF-\u043aB and COX-2 in complete Freund\u2019s adjuvant-induced arthritis model in rats. Int J Nanomed. 2021;16:133\u201345. https:\/\/doi.org\/10.2147\/IJN.S289828.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3511_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44395-025-00009-1","volume":"1","author":"S Sahin","year":"2025","unstructured":"Sahin S, Sarma S, Das A, Baishya B, Das AK, Deka MK. Spanlastics ocular delivery: a comprehensive review of formulation and therapeutic potential. Discov Pharm Sci. 2025;1(1):9. https:\/\/doi.org\/10.1007\/s44395-025-00009-1.","journal-title":"Discov Pharm Sci"},{"issue":"1-2","key":"3511_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","volume":"413","author":"S Kakkar","year":"2011","unstructured":"Kakkar S, Kaur IP. Spanlastics-a novel nanovesicular carrier system for ocular delivery. Int J Pharm. 2011;413(1\u20132):202\u201310. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.04.027.","journal-title":"Int J Pharm"},{"issue":"9","key":"3511_CR27","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s13346-025-01796-x","volume":"15","author":"SF Elhabal","year":"2025","unstructured":"Elhabal SF, El-Nabarawi M, Elrefai MFM, Teaima MH, Shoela MS, Khamis GM, et al. Nano-spanlastics-loaded dissolving microneedle patches for ketotifen fumarate: advanced strategies for allergic conjunctivitis treatment and molecular insights. Drug Deliv Transl Res. 2025;15(9):3161\u201384. https:\/\/doi.org\/10.1007\/s13346-025-01796-x.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3511_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/0122117385286921240103113543","volume":"13","author":"K Dipanjan","year":"2025","unstructured":"Dipanjan K, Swarupananda M, Bhupendra GP. Unveiling spanlastics as a novel carrier for drug delivery: a review. Pharm Nanotechnol. 2025;13(1):133\u201342. https:\/\/doi.org\/10.2174\/0122117385286921240103113543.","journal-title":"Pharm Nanotechnol"},{"key":"3511_CR29","doi-asserted-by":"publisher","unstructured":"Agha OA, Girgis GNS, El-Sokkary MMA, Soliman OAE-A. Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study. Int J Pharm: X. 2023;6:100201. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100201.","DOI":"10.1016\/j.ijpx.2023.100201"},{"issue":"4","key":"3511_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/08982104.2022.2025828","volume":"32","author":"MH Shukr","year":"2022","unstructured":"Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box\u2013Behnken design and in vivo evaluation. J Liposome Res. 2022;32(4):354\u201364. https:\/\/doi.org\/10.1080\/08982104.2022.2025828.","journal-title":"J Liposome Res"},{"key":"3511_CR31","doi-asserted-by":"publisher","first-page":"100228","DOI":"10.1016\/j.ijpx.2023.100228","volume":"7","author":"M Yasser","year":"2024","unstructured":"Yasser M, El Naggar EE, Elfar N, Teaima MH, El-Nabarawi MA, Elhabal SF. Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies. Int J Pharm: X. 2024;7:100228. https:\/\/doi.org\/10.1016\/j.ijpx.2023.100228.","journal-title":"Int J Pharm: X"},{"issue":"7","key":"3511_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1208\/s12249-025-03205-5","volume":"26","author":"NM Sheta","year":"2025","unstructured":"Sheta NM, Shamma RN, Hussein RRS, Salem SAM, Abdelaty LN, Abd El Gawad MM, et al. Voriconazole loaded spanlastics: design, formulation, optimization, and randomized controlled clinical insights for vulvovaginal candidiasis therapy. AAPS PharmSciTech. 2025;26(7):219. https:\/\/doi.org\/10.1208\/s12249-025-03205-5.","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"3511_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/scipharm89020024","volume":"89","author":"A Saleh","year":"2021","unstructured":"Saleh A, Khalifa M, Shawky S, Bani-Ali A, Eassa H. Zolmitriptan intranasal spanlastics for enhanced migraine treatment; formulation parameters optimized via quality by design approach. Sci Pharm. 2021;89(2):24. https:\/\/doi.org\/10.3390\/scipharm89020024.","journal-title":"Sci Pharm"},{"issue":"1","key":"3511_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/ph14010068","volume":"14","author":"EA Mazyed","year":"2021","unstructured":"Mazyed EA, Helal DA, Elkhoudary MM, Abd Elhameed AG, Yasser M. Formulation and optimization of nanospanlastics for improving the bioavailability of green tea epigallocatechin gallate. Pharmaceuticals (Basel). 2021;14(1):68. https:\/\/doi.org\/10.3390\/ph14010068.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3511_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12369","author":"OL Ugorji","year":"2022","unstructured":"Ugorji OL, Umeh ONC, Agubata CO, Adah D, Obitte NC, Chukwu A. The effect of niosome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line. Heliyon. 2022. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12369.","journal-title":"Heliyon"},{"key":"3511_CR36","doi-asserted-by":"publisher","first-page":"107247","DOI":"10.1016\/j.jddst.2025.107247","volume":"112","author":"FR Aljohani","year":"2025","unstructured":"Aljohani FR, Alanazi AA, Albalawi AZA, Soliman GM, Qushawy M, Arafa MF, et al. Development and evaluation of fusidic acid myrrh oil organogel for the reversal of Gram-negative bacterial resistance and improvement of wound-healing potential. J Drug Deliv Sci Technol. 2025;112:107247. https:\/\/doi.org\/10.1016\/j.jddst.2025.107247.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3511_CR37","doi-asserted-by":"publisher","first-page":"125735","DOI":"10.1016\/j.ijpharm.2025.125735","volume":"678","author":"AS Alanazi","year":"2025","unstructured":"Alanazi AS, Alanazi RM, Salama A, Qushawy M, Arafa MF, Elsherbiny N, et al. Polycaprolactone nanocapsule-loaded carbopol hydrogel enhances fusidic acid efficacy against Gram-negative bacteria and promotes wound healing. Int J Pharm. 2025;678:125735. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125735.","journal-title":"Int J Pharm"},{"issue":"6","key":"3511_CR38","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jbm.820060609","volume":"6","author":"IR Schmolka","year":"1972","unstructured":"Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res. 1972;6(6):571\u201382.","journal-title":"J Biomed Mater Res"},{"key":"3511_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/03639045.2016.1254239","volume":"43","author":"GM Soliman","year":"2017","unstructured":"Soliman GM, Fetih G, Abbas AM. Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation. Drug Dev Ind Pharm. 2017;43:399\u2013408. https:\/\/doi.org\/10.1080\/03639045.2016.1254239.","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"3511_CR40","first-page":"1022","volume":"16","author":"A Kumari","year":"2012","unstructured":"Kumari A, Sharma N, Sharma PK, Goyal N. Rheological evaluation of thermoreversible and mucoadhesive nasal gels of zolmitriptan. Eur Rev Med Pharmacol Sci. 2012;16(8):1022\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3511_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/gels11010013","author":"C Chaiwut","year":"2024","unstructured":"Chaiwut C, Tadtong S, Akachaipaibul P, Jiaranaikulwanitch J, Singh S, Okonogi S, et al. Thermosensitive in situ ophthalmic gel for effective local delivery and antifungal activity of ketoconazole nanoparticles. Gels. 2024. https:\/\/doi.org\/10.3390\/gels11010013.","journal-title":"Gels"},{"issue":"3","key":"3511_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/pharmaceutics11030140","volume":"11","author":"C Mircioiu","year":"2019","unstructured":"Mircioiu C, Voicu V, Anuta V, Tudose A, Celia C, Paolino D, et al. Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics. 2019;11(3):140.","journal-title":"Pharmaceutics"},{"key":"3511_CR43","doi-asserted-by":"publisher","unstructured":"Berkow EL, Lockhart SR, Ostrosky-Zeichner L. Antifungal susceptibility testing: current approaches. Clin Microbiol Rev. 2020; 33(3): https:\/\/doi.org\/10.1128\/cmr.00069-19.","DOI":"10.1128\/cmr.00069-19"},{"key":"3511_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17091218","author":"M Gackowski","year":"2025","unstructured":"Gackowski M, Froelich A, Kordyl O, D\u0142ugaszewska J, Kami\u0144ska D, Schneider R, et al. Formulation studies on microemulsion-based polymer gels loaded with voriconazole for the treatment of skin mycoses. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17091218.","journal-title":"Pharmaceutics"},{"issue":"4","key":"3511_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s12247-025-10031-6","volume":"20","author":"R Masareddy","year":"2025","unstructured":"Masareddy R, Patted P, Patil AS, Chougule KR. Development of bimatoprost-loaded nano spanlastic in-situ gel for ophthalmic drug delivery: a box-behnken optimization approach with in vitro and ex vivo characterization. J Pharm Innov. 2025;20(4):130. https:\/\/doi.org\/10.1007\/s12247-025-10031-6.","journal-title":"J Pharm Innov"},{"key":"3511_CR46","doi-asserted-by":"publisher","unstructured":"Ameeduzzafar, Imam SS, Bukhari SNA, Ali A. Preparation and evaluation of novel chitosan: gelrite ocular system containing besifloxacin for topical treatment of bacterial conjunctivitis: scintigraphy, ocular irritation and retention assessment. Artif Cells Nanomed Biotechnol. 2018;46(5):959\u201367. https:\/\/doi.org\/10.1080\/21691401.2017.1349779.","DOI":"10.1080\/21691401.2017.1349779"},{"key":"3511_CR47","doi-asserted-by":"publisher","first-page":"101134","DOI":"10.1016\/j.jddst.2019.101134","volume":"53","author":"A Khattab","year":"2019","unstructured":"Khattab A, Marzok S, Ibrahim M. Development of optimized mucoadhesive thermosensitive pluronic based in situ gel for controlled delivery of latanoprost: antiglaucoma efficacy and stability approaches. J Drug Deliv Sci Technol. 2019;53:101134. https:\/\/doi.org\/10.1016\/j.jddst.2019.101134.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3511_CR48","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/03639045.2019.1579827","volume":"45","author":"MA El-Nabarawi","year":"2019","unstructured":"El-Nabarawi MA, Abd El Rehem RT, Teaima M, Abary M, El-Mofty HM, Khafagy MM, et al. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro\/in vivo and histopathological studies. Drug Dev Ind Pharm. 2019;45(6):922\u201336. https:\/\/doi.org\/10.1080\/03639045.2019.1579827.","journal-title":"Drug Dev Ind Pharm"},{"key":"3511_CR49","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.2147\/dddt.S265167","volume":"14","author":"F Badria","year":"2020","unstructured":"Badria F, Mazyed E. Formulation of nanospanlastics as a promising approach for improving the topical delivery of a natural leukotriene inhibitor (3-acetyl-11-keto-\u03b2-boswellic acid): statistical optimization, in vitro characterization, and ex vivo permeation study. Drug Des Devel Ther. 2020;14:3697\u2013721. https:\/\/doi.org\/10.2147\/dddt.S265167.","journal-title":"Drug Des Devel Ther"},{"key":"3511_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/dddt.S95905","volume":"10","author":"GF Balata","year":"2016","unstructured":"Balata GF, Essa EA, Shamardl HA, Zaidan SH, Abourehab MA. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Devel Ther. 2016;10:117\u201328. https:\/\/doi.org\/10.2147\/dddt.S95905.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"3511_CR51","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/molecules18010768","volume":"18","author":"N Anarjan","year":"2013","unstructured":"Anarjan N, Tan CP. Effects of selected polysorbate and sucrose ester emulsifiers on the physicochemical properties of astaxanthin nanodispersions. Molecules. 2013;18(1):768\u201377. https:\/\/doi.org\/10.3390\/molecules18010768.","journal-title":"Molecules"},{"issue":"15","key":"3511_CR52","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.3390\/molecules25153455","volume":"25","author":"E Rosa","year":"2020","unstructured":"Rosa E, Diaferia C, Gallo E, Morelli G, Accardo A. Stable formulations of peptide-based nanogels. Molecules. 2020;25(15):3455. https:\/\/doi.org\/10.3390\/molecules25153455.","journal-title":"Molecules"},{"key":"3511_CR53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcis.2021.02.113","volume":"594","author":"J Cerar","year":"2021","unstructured":"Cerar J, Jamnik A, Szil\u00e1gyi I, Tom\u0161i\u010d M. Solvation of nonionic poly(ethylene oxide) surfactant Brij 35 in organic and aqueous-organic solvents. J Colloid Interface Sci. 2021;594:150\u20139. https:\/\/doi.org\/10.1016\/j.jcis.2021.02.113.","journal-title":"J Colloid Interface Sci"},{"issue":"4","key":"3511_CR54","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1007\/s12247-023-09800-y","volume":"18","author":"MS Ibrahim","year":"2023","unstructured":"Ibrahim MS, Elkady OA, Amer MA, Noshi SH. Exploiting response surface D-optimal design study for preparation and optimization of spanlastics loaded with miconazole nitrate as a model antifungal drug for topical application. J Pharm Innov. 2023;18(4):2402\u201318. https:\/\/doi.org\/10.1007\/s12247-023-09800-y.","journal-title":"J Pharm Innov"},{"issue":"1","key":"3511_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.07.050","volume":"530","author":"FE Abdelrahman","year":"2017","unstructured":"Abdelrahman FE, Elsayed I, Gad MK, Elshafeey AH, Mohamed MI. Response surface optimization, Ex vivo and In vivo investigation of nasal spanlastics for bioavailability enhancement and brain targeting of risperidone. Int J Pharm. 2017;530(1):1\u201311. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.050.","journal-title":"Int J Pharm"},{"issue":"7","key":"3511_CR56","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3109\/10717544.2014.942811","volume":"23","author":"AN ElMeshad","year":"2016","unstructured":"ElMeshad AN, Mohsen AM. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle. Drug Deliv. 2016;23(7):2115\u201323. https:\/\/doi.org\/10.3109\/10717544.2014.942811.","journal-title":"Drug Deliv"},{"issue":"2","key":"3511_CR57","first-page":"69","volume":"7","author":"V Akbari","year":"2015","unstructured":"Akbari V, Abedi D, Pardakhty A, Sadeghi-Aliabadi H. Release studies on ciprofloxacin loaded non-ionic surfactant vesicles. Avicenna J Med Biotechnol. 2015;7(2):69\u201375.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3511_CR58","doi-asserted-by":"publisher","first-page":"102725","DOI":"10.1016\/j.jddst.2021.102725","volume":"65","author":"E Alaaeldin","year":"2021","unstructured":"Alaaeldin E, Mostafa M, Mansour HF, Soliman GM. Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: fabrication and cytotoxic studies against breast cancer cell lines. J Drug Deliv Sci Technol. 2021;65:102725.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3511_CR59","doi-asserted-by":"publisher","unstructured":"Zaid Alkilani A, Alkhaldi Ra, Basheer HA, Amro BI, Alhusban MA. Fabrication of thymoquinone and ascorbic acid-loaded spanlastics gel for hyperpigmentation: In vitro release, cytotoxicity, and skin permeation studies. Pharmaceutics. 2025;17(1):48. https:\/\/doi.org\/10.3390\/pharmaceutics17010048.","DOI":"10.3390\/pharmaceutics17010048"},{"key":"3511_CR60","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.2147\/ijn.S132780","volume":"12","author":"S Shen","year":"2017","unstructured":"Shen S, Wu Y, Liu Y, Wu D. High drug-loading nanomedicines: progress, current status, and prospects. Int J Nanomedicine. 2017;12:4085\u2013109. https:\/\/doi.org\/10.2147\/ijn.S132780.","journal-title":"Int J Nanomedicine"},{"key":"3511_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121614","author":"HI Almohamady","year":"2024","unstructured":"Almohamady HI, Mortagi Y, Gad S, Zaitone S, Alshaman R, Alattar A, et al. Spanlastic nano-vesicles: a novel approach to improve the dissolution, bioavailability, and pharmacokinetic behavior of famotidine. Pharmaceuticals (Basel). 2024. https:\/\/doi.org\/10.3390\/ph17121614.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3511_CR62","doi-asserted-by":"publisher","first-page":"100837","DOI":"10.1016\/j.mtbio.2023.100837","volume":"23","author":"A Moammeri","year":"2023","unstructured":"Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, et al. Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100837.","journal-title":"Mater Today Bio"},{"issue":"8","key":"3511_CR63","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/pharmaceutics14081727","volume":"14","author":"AI Mekkawy","year":"2022","unstructured":"Mekkawy AI, Eleraky NE, Soliman GM, Elnaggar MG, Elnaggar MG. Combinatorial therapy of letrozole- and quercetin-loaded spanlastics for enhanced cytotoxicity against MCF-7 breast cancer cells. Pharmaceutics. 2022;14(8):1727. https:\/\/doi.org\/10.3390\/pharmaceutics14081727.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3511_CR64","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13346-020-00814-4","volume":"11","author":"NM Sallam","year":"2021","unstructured":"Sallam NM, Sanad RAB, Ahmed MM, Khafagy ELS, Ghorab M, Gad S. Impact of the mucoadhesive lyophilized wafer loaded with novel carvedilol nano-spanlastics on biochemical markers in the heart of spontaneously hypertensive rat models. Drug Deliv Transl Res. 2021;11(3):1009\u201336. https:\/\/doi.org\/10.1007\/s13346-020-00814-4.","journal-title":"Drug Deliv Transl Res"},{"issue":"2","key":"3511_CR65","doi-asserted-by":"publisher","first-page":"1900105","DOI":"10.1002\/ejlt.201900105","volume":"122","author":"F Hasibi","year":"2020","unstructured":"Hasibi F, Nasirpour A, Varshosaz J, Garc\u00eda-Manrique P, Blanco-L\u00f3pez MC, Guti\u00e9rrez G, et al. Formulation and characterization of taxifolin-loaded lipid nanovesicles (liposomes, niosomes, and transfersomes) for beverage fortification. Eur J Lipid Sci Technol. 2020;122(2):1900105. https:\/\/doi.org\/10.1002\/ejlt.201900105.","journal-title":"Eur J Lipid Sci Technol"},{"issue":"1","key":"3511_CR66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12247-025-10216-z","volume":"21","author":"KM Abdel-Haleem","year":"2025","unstructured":"Abdel-Haleem KM, Shamma RN, Abd El Gawad MM, Sheta NM. Tailoring voriconazole novasomes: formulation, characterization, statistical optimization, ex-vivo permeation, and microbiological revelations. J Pharm Innov. 2025;21(1):12. https:\/\/doi.org\/10.1007\/s12247-025-10216-z.","journal-title":"J Pharm Innov"},{"issue":"11","key":"3511_CR67","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/pharmaceutics14112405","volume":"14","author":"MH Teaima","year":"2022","unstructured":"Teaima MH, Helal DA, Alsofany JM, El-Nabarawi MA, Yasser M. Ion-triggered in situ gelling intranasal spray of dronedarone hydrochloride nanocarriers: in vitro optimization and in vivo pharmacokinetic appraisal. Pharmaceutics. 2022;14(11):2405. https:\/\/doi.org\/10.3390\/pharmaceutics14112405.","journal-title":"Pharmaceutics"},{"key":"3511_CR68","doi-asserted-by":"publisher","first-page":"107790","DOI":"10.1016\/j.jddst.2025.107790","volume":"115","author":"E Abohashem","year":"2026","unstructured":"Abohashem E, Sabry SA, Saber MY, El-Megrab NA, Gomaa E. Optimized nano-bilosomes loaded ocular insert as a promising approach for boosting voriconazole ocular bioavailability: in-vitro, microbiological, and in-vivo assessments. J Drug Deliv Sci Technol. 2026;115:107790. https:\/\/doi.org\/10.1016\/j.jddst.2025.107790.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"3511_CR69","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","volume":"14","author":"Z N\u00e9meth","year":"2022","unstructured":"N\u00e9meth Z, Cs\u00f3ka I, Semnani Jazani R, Sipos B, Haspel H, Kozma G, et al. Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives. Pharmaceutics. 2022;14(9):1798. https:\/\/doi.org\/10.3390\/pharmaceutics14091798.","journal-title":"Pharmaceutics"},{"key":"3511_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/ijn.S287383","volume":"16","author":"S Mosallam","year":"2021","unstructured":"Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: In vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomed. 2021;16:119\u201332. https:\/\/doi.org\/10.2147\/ijn.S287383.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3511_CR71","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","volume":"24","author":"GA Abdelbary","year":"2017","unstructured":"Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309\u201319. https:\/\/doi.org\/10.1080\/10717544.2016.1247928.","journal-title":"Drug Deliv"},{"issue":"1","key":"3511_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijpharm.2003.09.020","volume":"269","author":"M Korhonen","year":"2004","unstructured":"Korhonen M, Hirvonen J, Peltonen L, Antikainen O, Yrj\u00e4n\u00e4inen L, Yliruusi J. Formation and characterization of three-component-sorbitan monoester surfactant, oil and water-creams. Int J Pharm. 2004;269(1):227\u201339. https:\/\/doi.org\/10.1016\/j.ijpharm.2003.09.020.","journal-title":"Int J Pharm"},{"key":"3511_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020138","author":"HF Salem","year":"2021","unstructured":"Salem HF, Kharshoum RM, Abou-Taleb HA, Farouk HO, Zaki RM. Fabrication and appraisal of simvastatin via tailored niosomal nanovesicles for transdermal delivery enhancement: in vitro and in vivo assessment. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020138.","journal-title":"Pharmaceutics"},{"key":"3511_CR74","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/S1984-82502009000300025","volume":"45","author":"SK Dey","year":"2009","unstructured":"Dey SK, Mandal B, Bhowmik M, Ghosh LKJBJoPS. Development and in vitro evaluation of letrozole loaded biodegradable nanoparticles for breast cancer therapy. Braz J Pharm Sci. 2009;45:585\u201391.","journal-title":"Braz J Pharm Sci"},{"issue":"12","key":"3511_CR75","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1039\/d3mh00717k","volume":"10","author":"SK Filippov","year":"2023","unstructured":"Filippov SK, Khusnutdinov R, Murmiliuk A, Inam W, Zakharova LY, Zhang H, et al. Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results. Mater Horiz. 2023;10(12):5354\u201370. https:\/\/doi.org\/10.1039\/d3mh00717k.","journal-title":"Mater Horiz"},{"issue":"10","key":"3511_CR76","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/polym9100521","volume":"9","author":"A Meister","year":"2017","unstructured":"Meister A, Blume A. (Cryo)transmission electron microscopy of phospholipid model membranes interacting with amphiphilic and polyphilic molecules. Polymers. 2017;9(10):521. https:\/\/doi.org\/10.3390\/polym9100521.","journal-title":"Polymers"},{"key":"3511_CR77","doi-asserted-by":"publisher","first-page":"122912","DOI":"10.1016\/j.ijpharm.2023.122912","volume":"638","author":"RK Eid","year":"2023","unstructured":"Eid RK, Arafa MF, Ashour DS, Essa EA, El-Wakil ES, Younis SS, et al. Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: in vitro and in vivo evaluations. Int J Pharm. 2023;638:122912. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122912.","journal-title":"Int J Pharm"},{"issue":"1","key":"3511_CR78","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bfopcu.2017.01.001","volume":"55","author":"NM Mori","year":"2017","unstructured":"Mori NM, Patel P, Sheth NR, Rathod LV, Ashara KC. Fabrication and characterization of film-forming voriconazole transdermal spray for the treatment of fungal infection. Bull Fac Pharm Cairo Univ. 2017;55(1):41\u201351. https:\/\/doi.org\/10.1016\/j.bfopcu.2017.01.001.","journal-title":"Bull Fac Pharm Cairo Univ"},{"issue":"1","key":"3511_CR79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1006\/jcis.2001.8118","volume":"247","author":"MA L\u00f3pez-Quintela","year":"2002","unstructured":"L\u00f3pez-Quintela MA, Akahane A, Rodr\u00edguez C, Kunieda H. Thermotropic behavior of poly(oxyethylene) cholesterol ethers. J Colloid Interface Sci. 2002;247(1):186\u201392. https:\/\/doi.org\/10.1006\/jcis.2001.8118.","journal-title":"J Colloid Interface Sci"},{"issue":"11","key":"3511_CR80","doi-asserted-by":"publisher","first-page":"811","DOI":"10.31083\/ph.2010.0138","volume":"65","author":"H Abdelkader","year":"2010","unstructured":"Abdelkader H, Ismail S, Kamal A, Alany RG. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Pharmazie. 2010;65(11):811\u20137.","journal-title":"Pharmazie"},{"issue":"3","key":"3511_CR81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/pharmaceutics10030075","volume":"10","author":"H Ouyang","year":"2018","unstructured":"Ouyang H, Zheng AY, Heng PW, Chan LW. Effect of lipid additives and drug on the rheological properties of molten paraffin wax, degree of surface drug coating, and drug release in spray-congealed microparticles. Pharmaceutics. 2018;10(3):75. https:\/\/doi.org\/10.3390\/pharmaceutics10030075.","journal-title":"Pharmaceutics"},{"issue":"22","key":"3511_CR82","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1039\/D0CE00236D","volume":"22","author":"EJ Nilsson","year":"2020","unstructured":"Nilsson EJ, Lind TK, Scherer D, Skansberger T, Mortensen K, Engblom J, et al. Mechanisms of crystallisation in polysorbates and sorbitan esters. CrystEngComm. 2020;22(22):3840\u201353. https:\/\/doi.org\/10.1039\/D0CE00236D.","journal-title":"CrystEngComm"},{"key":"3511_CR83","doi-asserted-by":"publisher","first-page":"100295","DOI":"10.1016\/j.ijpx.2024.100295","volume":"8","author":"S Ahmed","year":"2024","unstructured":"Ahmed S, Attia H, Saher O, Fahmy AM. Augmented glycerosomes as a promising approach against fungal ear infection: optimization and microbiological, ex vivo and in vivo assessments. Int J Pharm: X. 2024;8:100295. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100295.","journal-title":"Int J Pharm: X"},{"issue":"48","key":"3511_CR84","doi-asserted-by":"publisher","first-page":"14779","DOI":"10.1021\/acs.langmuir.2c02413","volume":"38","author":"Y Liu","year":"2022","unstructured":"Liu Y, Binks BP. Fabrication of stable oleofoams with sorbitan ester surfactants. Langmuir. 2022;38(48):14779\u201388. https:\/\/doi.org\/10.1021\/acs.langmuir.2c02413.","journal-title":"Langmuir"},{"key":"3511_CR85","doi-asserted-by":"publisher","first-page":"123332","DOI":"10.1016\/j.ijbiomac.2023.123332","volume":"231","author":"R Yoksan","year":"2023","unstructured":"Yoksan R, Dang KM. The effect of polyethylene glycol sorbitan monostearate on the morphological characteristics and performance of thermoplastic starch\/biodegradable polyester blend films. Int J Biol Macromol. 2023;231:123332. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123332.","journal-title":"Int J Biol Macromol"},{"key":"3511_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040483","author":"R Khalid","year":"2025","unstructured":"Khalid R, Mahmood S, Mohamed Sofian Z, Chik Z, Ge Y. Development of rapidly dissolving microneedles integrated with valsartan-loaded nanoliposomes for transdermal drug delivery: in vitro and ex vivo evaluation. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17040483.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3511_CR87","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/coatings12030362","volume":"12","author":"H Xia","year":"2022","unstructured":"Xia H, Tang Y, Huang R, Liang J, Ma S, Chen D, et al. Nanoliposome use to improve the stability of phenylethyl resorcinol and serve as a skin penetration enhancer for skin whitening. Coatings. 2022;12(3):362. https:\/\/doi.org\/10.3390\/coatings12030362.","journal-title":"Coatings"},{"issue":"3","key":"3511_CR88","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jconrel.2009.10.024","volume":"142","author":"C Chen","year":"2010","unstructured":"Chen C, Han D, Cai C, Tang X. An overview of liposome lyophilization and its future potential. J Control Release. 2010;142(3):299\u2013311. https:\/\/doi.org\/10.1016\/j.jconrel.2009.10.024.","journal-title":"J Control Release"},{"issue":"15","key":"3511_CR89","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","volume":"58","author":"W Abdelwahed","year":"2006","unstructured":"Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688\u2013713.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3511_CR90","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bbamem.2003.12.006","volume":"1661","author":"WF Wolkers","year":"2004","unstructured":"Wolkers WF, Oldenhof H, Tablin F, Crowe JH. Preservation of dried liposomes in the presence of sugar and phosphate. Biochim Biophys Acta. 2004;1661(2):125\u201334. https:\/\/doi.org\/10.1016\/j.bbamem.2003.12.006.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3511_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","volume":"241","author":"AH El-Kamel","year":"2002","unstructured":"El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm. 2002;241(1):47\u201355. https:\/\/doi.org\/10.1016\/S0378-5173(02)00234-X.","journal-title":"Int J Pharm"},{"issue":"8","key":"3511_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/10717540701606426","volume":"14","author":"H Gupta","year":"2007","unstructured":"Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Sustained ocular drug delivery from a temperature and ph triggered novel in situ gel system. Drug Deliv. 2007;14(8):507\u201315. https:\/\/doi.org\/10.1080\/10717540701606426.","journal-title":"Drug Deliv"},{"issue":"1","key":"3511_CR93","doi-asserted-by":"publisher","first-page":"19430","DOI":"10.1038\/s41598-025-03418-5","volume":"15","author":"BA Abou-Taleb","year":"2025","unstructured":"Abou-Taleb BA, Abdelwahab IA. Comparative evaluation of nano ocular delivery systems loaded pH and thermosensitive in situ gels for Acanthamoeba keratitis treatment. Sci Rep. 2025;15(1):19430. https:\/\/doi.org\/10.1038\/s41598-025-03418-5.","journal-title":"Sci Rep"},{"issue":"4","key":"3511_CR94","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/gels10040267","volume":"10","author":"P Ad\u0131sano\u011flu","year":"2024","unstructured":"Ad\u0131sano\u011flu P, \u00d6zg\u00fcney I. Development and characterization of thermosensitive and bioadhesive ophthalmic formulations containing flurbiprofen solid dispersions. Gels. 2024;10(4):267. https:\/\/doi.org\/10.3390\/gels10040267.","journal-title":"Gels"},{"issue":"2","key":"3511_CR95","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/archopht.1981.03930010303017","volume":"99","author":"MB Abelson","year":"1981","unstructured":"Abelson MB, Udell IJ, Weston JH. Normal human tear pH by direct measurement. Arch Ophthalmol. 1981;99(2):301. https:\/\/doi.org\/10.1001\/archopht.1981.03930010303017.","journal-title":"Arch Ophthalmol."},{"issue":"1","key":"3511_CR96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/pharmaceutics4010243","volume":"4","author":"I Januleviciene","year":"2012","unstructured":"Januleviciene I, Siaudvytyte L, Barsauskaite R. Ophthalmic drug delivery in glaucoma-a review. Pharmaceutics. 2012;4(1):243\u201351. https:\/\/doi.org\/10.3390\/pharmaceutics4010243.","journal-title":"Pharmaceutics"},{"issue":"13","key":"3511_CR97","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1021\/la304836e","volume":"29","author":"R Basak","year":"2013","unstructured":"Basak R, Bandyopadhyay R. Encapsulation of hydrophobic drugs in Pluronic F127 micelles: Effects of drug hydrophobicity, solution temperature, and pH. Langmuir. 2013;29(13):4350\u20136. https:\/\/doi.org\/10.1021\/la304836e.","journal-title":"Langmuir"},{"key":"3511_CR98","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/dddt.S158018","volume":"12","author":"IM Abdulbaqi","year":"2018","unstructured":"Abdulbaqi IM, Darwis Y, Assi RA, Khan NAK. Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug Des Devel Ther. 2018;12:795\u2013813. https:\/\/doi.org\/10.2147\/dddt.S158018.","journal-title":"Drug Des Devel Ther"},{"key":"3511_CR99","doi-asserted-by":"publisher","unstructured":"Nurman S, Yulia R, Irmayanti, Noor E, Candra Sunarti T. The optimization of gel preparations using the active compounds of arabica coffee ground nanoparticles. Sci Pharm. 2019;87(4). https:\/\/doi.org\/10.3390\/scipharm87040032.","DOI":"10.3390\/scipharm87040032"},{"key":"3511_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/polym15020355","author":"A Lupu","year":"2023","unstructured":"Lupu A, Rosca I, Gradinaru VR, Bercea M. Temperature induced gelation and antimicrobial properties of pluronic F127 based systems. Polymers. 2023. https:\/\/doi.org\/10.3390\/polym15020355.","journal-title":"Polymers"},{"issue":"2","key":"3511_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0168-3659(00)00215-7","volume":"67","author":"T Moore","year":"2000","unstructured":"Moore T, Croy S, Mallapragada S, Pandit N. Experimental investigation and mathematical modeling of Pluronic\u00ae F127 gel dissolution: drug release in stirred systems. J Control Release. 2000;67(2):191\u2013202. https:\/\/doi.org\/10.1016\/S0168-3659(00)00215-7.","journal-title":"J Control Release"},{"issue":"1","key":"3511_CR102","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1038\/s41598-024-60883-0","volume":"14","author":"U Niroumand","year":"2024","unstructured":"Niroumand U, Motazedian MH, Ahmadi F, Asgari Q, Bahreini MS, Ghasemiyeh P, et al. Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis. Sci Rep. 2024;14(1):10073. https:\/\/doi.org\/10.1038\/s41598-024-60883-0.","journal-title":"Sci Rep"},{"issue":"12","key":"3511_CR103","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/ph17121614","volume":"17","author":"HI Almohamady","year":"2024","unstructured":"Almohamady HI, Mortagi Y, Gad S, Zaitone S, Alshaman R, Alattar A, et al. Spanlastic nano-vesicles: a novel approach to improve the dissolution, bioavailability, and pharmacokinetic behavior of famotidine. Pharmaceuticals (Basel). 2024;17(12):1614. https:\/\/doi.org\/10.3390\/ph17121614.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"3511_CR104","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1080\/10717544.2022.2139021","volume":"29","author":"Y Mou","year":"2022","unstructured":"Mou Y, Zhang P, Lai W-F, Zhang D. Design and applications of liposome-in-gel as carriers for cancer therapy. Drug Deliv. 2022;29(1):3245\u201355. https:\/\/doi.org\/10.1080\/10717544.2022.2139021.","journal-title":"Drug Deliv"},{"issue":"1","key":"3511_CR105","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/10717544.2017.1419512","volume":"25","author":"AR Fares","year":"2018","unstructured":"Fares AR, ElMeshad AN, Kassem MAA. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123\/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study. Drug Deliv. 2018;25(1):132\u201342. https:\/\/doi.org\/10.1080\/10717544.2017.1419512.","journal-title":"Drug Deliv"},{"issue":"3","key":"3511_CR106","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1208\/pt070378","volume":"7","author":"HA Merchant","year":"2017","unstructured":"Merchant HA, Shoaib HM, Tazeen J, Yousuf RI. Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: a technical note. AAPS PharmSciTech. 2017;7(3):78. https:\/\/doi.org\/10.1208\/pt070378.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3511_CR107","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.03.051","volume":"418","author":"J Siepmann","year":"2011","unstructured":"Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418(1):6\u201312. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.03.051.","journal-title":"Int J Pharm"},{"issue":"10","key":"3511_CR108","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/jps.2600501018","volume":"50","author":"T Higuchi","year":"1961","unstructured":"Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50(10):874\u20135. https:\/\/doi.org\/10.1002\/jps.2600501018.","journal-title":"J Pharm Sci"},{"issue":"1","key":"3511_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-3659(87)90035-6","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37\u201342. https:\/\/doi.org\/10.1016\/0168-3659(87)90035-6.","journal-title":"J Control Release"},{"issue":"42","key":"3511_CR110","doi-asserted-by":"publisher","first-page":"12532","DOI":"10.1021\/acs.langmuir.0c01980","volume":"36","author":"RA Bataglioli","year":"2020","unstructured":"Bataglioli RA, Rocha Neto JBM, Le\u00e3o BS, Germiniani LGL, Taketa TB, Beppu MM. Interplay of the assembly conditions on drug transport mechanisms in polyelectrolyte multilayer films. Langmuir. 2020;36(42):12532\u201344. https:\/\/doi.org\/10.1021\/acs.langmuir.0c01980.","journal-title":"Langmuir"},{"key":"3511_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105000","author":"R Smith","year":"2023","unstructured":"Smith R, Brogden N, Fiegel J. Sprayable ciprofloxacin-loaded poloxamer hydrogels for wound infection treatment. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.105000.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3511_CR112","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/ijn.S15057","volume":"6","author":"S Nie","year":"2011","unstructured":"Nie S, Hsiao WL, Pan W, Yang Z. Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies. Int J Nanomed. 2011;6:151\u201366. https:\/\/doi.org\/10.2147\/ijn.S15057.","journal-title":"Int J Nanomed"},{"issue":"1","key":"3511_CR113","doi-asserted-by":"publisher","first-page":"6395840","DOI":"10.1155\/2019\/6395840","volume":"2019","author":"P Manikandan","year":"2019","unstructured":"Manikandan P, Abdel-hadi A, Randhir Babu Singh Y, Revathi R, Anita R, Banawas S, et al. Fungal keratitis: epidemiology, rapid detection, and antifungal susceptibilities of fusarium and aspergillus isolates from corneal scrapings. Biomed Res Int. 2019;2019(1):6395840. https:\/\/doi.org\/10.1155\/2019\/6395840.","journal-title":"Biomed Res Int"},{"issue":"3\u20134","key":"3511_CR114","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11046-014-9837-2","volume":"179","author":"AF Leal","year":"2015","unstructured":"Leal AF, Leite MC, Medeiros CS, Cavalcanti IM, Wanderley AG, Magalh\u00e3es NS, et al. Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis. Mycopathologia. 2015;179(3\u20134):225\u20139. https:\/\/doi.org\/10.1007\/s11046-014-9837-2.","journal-title":"Mycopathologia"},{"issue":"8","key":"3511_CR115","doi-asserted-by":"publisher","first-page":"e00225-24","DOI":"10.1128\/aac.00225-24","volume":"68","author":"M-I Beredaki","year":"2024","unstructured":"Beredaki M-I, Arendrup MC, Pournaras S, Meletiadis J. Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic\/pharmacodynamic model. Antimicrob Agents Chemother. 2024;68(8):e00225-24. https:\/\/doi.org\/10.1128\/aac.00225-24.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3511_CR116","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/pathogens11010073","volume":"11","author":"A Alakkad","year":"2022","unstructured":"Alakkad A, Stapleton P, Schlosser C, Murdan S, Odunze U, Schatzlein A, et al. Amphotericin B polymer nanoparticles show efficacy against Candida species biofilms. Pathogens. 2022;11(1):73. https:\/\/doi.org\/10.3390\/pathogens11010073.","journal-title":"Pathogens"},{"issue":"1","key":"3511_CR117","doi-asserted-by":"publisher","first-page":"14382","DOI":"10.1038\/s41598-024-63149-x","volume":"14","author":"IT Radwan","year":"2024","unstructured":"Radwan IT, El-Sherbiny IM, Metwally NH. Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier. Sci Rep. 2024;14(1):14382. https:\/\/doi.org\/10.1038\/s41598-024-63149-x.","journal-title":"Sci Rep"},{"issue":"1","key":"3511_CR118","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1208\/pt070113","volume":"7","author":"PK Pawar","year":"2006","unstructured":"Pawar PK, Majumdar DK. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech. 2006;7(1):E13. https:\/\/doi.org\/10.1208\/pt070113.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"3511_CR119","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acs.molpharmaceut.3c00195","volume":"20","author":"I De Hoon","year":"2023","unstructured":"De Hoon I, Boukherroub R, De Smedt SC, Szunerits S, Sauvage F. In vitro and ex vivo models for assessing drug permeation across the cornea. Mol Pharm. 2023;20(7):3298\u2013319. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00195.","journal-title":"Mol Pharm"},{"key":"3511_CR120","doi-asserted-by":"publisher","unstructured":"Saini H, Rapolu Y, Razdan K, Nirmala, Sinha VR. Spanlastics: a novel elastic drug delivery system with potential applications via multifarious routes of administration. J Drug Target. 2023;31(10):999\u20131012. https:\/\/doi.org\/10.1080\/1061186X.2023.2274805.","DOI":"10.1080\/1061186X.2023.2274805"},{"issue":"1","key":"3511_CR121","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. J Nanobiotechnology. 2023;21(1):232. https:\/\/doi.org\/10.1186\/s12951-023-01992-2.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3511_CR122","doi-asserted-by":"publisher","first-page":"6590361","DOI":"10.1155\/2016\/6590361","volume":"2016","author":"A Khare","year":"2016","unstructured":"Khare A, Singh I, Pawar P, Grover K. Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application. J Drug Deliv. 2016;2016(1):6590361. https:\/\/doi.org\/10.1155\/2016\/6590361.","journal-title":"J Drug Deliv"},{"key":"3511_CR123","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000825","author":"LM Andrade","year":"2016","unstructured":"Andrade LM, Rocha KAD, De S\u00e1 FAP, Marreto RN, Lima EM, Gratieri T, et al. Voriconazole-loaded nanostructured lipid carriers for ocular drug delivery. Cornea. 2016. https:\/\/doi.org\/10.1097\/ICO.0000000000000825.","journal-title":"Cornea"},{"issue":"2","key":"3511_CR124","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/1389201021999200820154918","volume":"22","author":"Q Tang","year":"2021","unstructured":"Tang Q, Zhu D, Xiaodi X, Zilin Z, Xiangyu Y, Hongmei S, et al. Nanosuspension as an efficient carrier for improved ocular permeation of voriconazole. Curr Pharm Biotechnol. 2021;22(2):245\u201353. https:\/\/doi.org\/10.2174\/1389201021999200820154918.","journal-title":"Curr Pharm Biotechnol"},{"key":"3511_CR125","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.2147\/ijn.S268208","volume":"15","author":"GA El-Emam","year":"2020","unstructured":"El-Emam GA, Girgis GNS, El-Sokkary MMA, El-Azeem Soliman OA, Abd El Gawad A. Ocular inserts of voriconazole-loaded proniosomal gels: formulation, evaluation and microbiological studies. Int J Nanomedicine. 2020;15:7825\u201340. https:\/\/doi.org\/10.2147\/ijn.S268208.","journal-title":"Int J Nanomedicine"},{"key":"3511_CR126","doi-asserted-by":"publisher","first-page":"122068","DOI":"10.1016\/j.ijpharm.2022.122068","volume":"625","author":"SS Ibrahim","year":"2022","unstructured":"Ibrahim SS, Abd-allah H. Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: design, in vitro characterization, and in vivo anti-inflammatory evaluation. Int J Pharm. 2022;625:122068. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122068.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03511-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03511-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:30:53Z","timestamp":1789432253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03511-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":126,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03511-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report there are no competing interests to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"296"}}